Login
$CDXS
$1.26 -$0.02 (1.56%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Alison Moore Also a director
President and Chief Executive Officer
59 Not stated Not stated $2,323,279
Stefan Lutz
Chief Scientific Officer
56 Since 2025
1 year
Not stated $1,123,094
Georgia Erbez
See Remarks
Title from the Form 4 dated Oct 12, 2026
59 Not stated Not stated $1,350,930

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
Not stated
the proxy does not say
Average tenure
3.8 years
from year joined
CEO also chairs the board
No
Stephen G. Dilly
Director Age On board Independent Committees Other public boards 2025 pay Source
Stephen G. Dilly
66 2020
6 years
Not stated None stated None stated Not stated
Alison Moore
59 2025
1 year
Not stated None stated Artiva Biotherapeutics, Inc. Paid as CEO
David V. Smith
66 2016
10 years
Not stated
audit · Chair compensation nominating and corporate governance strategy
IO Biotech $265,000
Raymond De Vré
58 2024
2 years
Not stated
science and technology
EQL Pharma AB Not stated
Rahul Singhvi
61 2022
4 years
Not stated
science and technology
Kairos Pharmaceuticals, Ltd. Not stated
Esther Martinborough
60 2021
5 years
Not stated
science and technology · Chair strategy
None stated Not stated
Cynthia Collins Leaving at the meeting
68 2025
1 year
Not stated
compensation · Chair
None stated $353,278
H. Stewart Parker Leaving at the meeting
70 2022
4 years
Not stated
audit strategy · Chair
Sangamo Therapeutics, Inc. $195,000
Christos Richards Leaving at the meeting
68 2025
1 year
Not stated
nominating and corporate governance · Chair
None stated $370,426

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support